Filtered By:
Source: International Journal of Cardiology
Condition: Atrial Fibrillation
This page shows you your search results in order of date.
Order by Relevance | Date
Total 388 results found since Jan 2013.
ISCHEMIC STROKE AND MAJOR BLEEDING WHILE ON DIRECT ORAL ANTICOAGULANTS IN NA ÏVE PATIENTS WITH ATRIAL FIBRILLATION: IMPACT OF RESUMPTION OR DISCONTINUATION OF ANTICOAGULANT TREATMENT. A population-based study.
We assessed the cumulative incidence of recurrent stroke, major bleeding and all-cause mortality associated with restarting antithrombotic treatment, in patients experiencing an anticoagulation-related event (stroke or major bleeding), occurred during anticoagulation therapy for AF.Methods and Results.We performed a retrospective population-based analysis on linked claims data of patients resident in the Veneto Region, treated with DOACs for AF and discharged (2013 −2020) from the hospital for stroke, intracranial haemorrhage (ICH), and major bleeding.
Source: International Journal of Cardiology - September 16, 2023 Category: Cardiology Authors: N. Gennaro, E. Ferroni, M. Zorzi, G. Denas, V. Pengo Source Type: research
Detection rates of asymptomatic carotid artery stenosis and atrial fibrillation by selective screening of patients without cardiovascular disease
Individuals with significant asymptomatic carotid artery stenosis (ACAS) and atrial fibrillation (AF) could benefit from specific interventions to prevent heart attack and stroke, but are often clinically ‘silent’. We aimed to determine detection rate of ACAS and AF by screening, targeting a population at increased cardiovascular risk.
Source: International Journal of Cardiology - August 10, 2023 Category: Cardiology Authors: Michiel H.F. Poorthuis, Paul Sherliker, Gert J. de Borst, Rachel Clack, Sarah Lewington, Robert Clarke, Richard Bulbulia, Alison Halliday Source Type: research
Detection rates of asymptomatic carotid stenosis and atrial fibrillation by selective screening of patients without cardiovascular disease
Individuals with significant asymptomatic carotid stenosis (ACAS) and atrial fibrillation (AF) could benefit from specific interventions to prevent heart attack and stroke, but are often clinically ‘silent’. We aimed to determine detection rate of ACAS and AF by screening targeting a population at increased cardiovascular risk.
Source: International Journal of Cardiology - August 10, 2023 Category: Cardiology Authors: Michiel H.F. Poorthuis, Paul Sherliker, Gert J. de Borst, Rachel Clack, Sarah Lewington, Robert Clarke, Richard Bulbulia, Alison Halliday Source Type: research
Assessing atrial myopathy with cardiac magnetic resonance imaging in embolic stroke of undetermined source
Left atrial myopathy has been implicated in atrial fibrillation (AF)-related stroke and embolic stroke of undetermined source (ESUS).
Source: International Journal of Cardiology - July 25, 2023 Category: Cardiology Authors: Stavroula Papapostolou, John Kearns, Benedict T. Costello, Jessica O'Brien, Murray Rudman, Mark C. Thompson, Geoffrey Cloud, Dion Stub, Andrew J. Taylor Source Type: research
Risk of cardioembolic ischemic events and relation to atrial fibrillation/flutter in patients with arrhythmogenic cardiomyopathy during a long-term follow-up
This study sought to determine the occurrence of cardioembolic ischemic events (CIEs) in ACM patients and to identify clinical and imaging predictors of CIEs.
Source: International Journal of Cardiology - July 21, 2023 Category: Cardiology Authors: Elisabetta Toso, Francesca De Lio, Pier Paolo Bocchino, Claudia Raineri, Francesco Fioravanti, Elena Maria Richiardi, Gianluca Marcelli, Tania Sacco, Carla Giustetto, Fiorenzo Gaita Source Type: research
Surgical ablation in hypertrophic obstructive cardiomyopathy: What is the real deal?
Atrial fibrillation (AF) is the most common tachyarrhythmia in patients with hypertrophic obstructive cardiomyopathy (HOCM), with an estimated prevalence of approximately 20% [1]. AF is associated with malignant outcomes in patients with HOCM, with an increased risk of embolic stroke, heart failure, severe functional impairment and mortality [2]. Furthermore, AF is poorly tolerated by patients with HOCM, with increased heart failure episodes, hemodynamic instability and impaired quality of life [3].
Source: International Journal of Cardiology - July 8, 2023 Category: Cardiology Authors: Alessandra Sala, Ottavio Alfieri Tags: Editorial Source Type: research
The real world of stroke incidence in patients with hypertrophic cardiomyopathy
We have read a paper with great interest written by Fumagalli and colleagues concerning “the incidence of stroke in patients with hypertrophic cardiomyopathy (HCM) among different heart rhythm” [1]. In this paper, the authors found that stroke rates in HCM patients no prior history of atrial fibrillation (AF), stroke rates were similar in those with de novo AF or stable sinus rate (SR). And they further observed that severe left atrium dilatation was a powerful risk factor, irrespective of AF. The results provided evidence for the anticoagulation strategies to prevent stroke in patients with HCM.
Source: International Journal of Cardiology - July 7, 2023 Category: Cardiology Authors: Xinru Chen Tags: Letter to the Editor Source Type: research
Effect of prior anticoagulation therapy on stroke severity and in-hospital outcomes in patients with acute ischemic stroke and atrial fibrillation
We aimed to assess the prevalence of prior anticoagulation therapy (warfarin or non-vitamin K antagonist oral anticoagulants [NOACs]) among patients with acute ischemic stroke (AIS) and atrial fibrillation (AF) in China and investigate the associations between prior anticoagulation therapy and initial stroke severity and in-hospital outcomes.
Source: International Journal of Cardiology - May 29, 2023 Category: Cardiology Authors: Lue Zhou, Yapeng Li, Xin Yang, Hongqiu Gu, Yanran Duan, Hang Fu, Anran Wang, Kai Liu, Yuan Gao, Bo Song, Yusheng Li, Yingyu Jiang, Jing Zhang, Chunjuan Wang, Meng Wang, Zixiao Li, Yuming Xu, Chengzeng Wang, Yongjun Wang Source Type: research
Incidence of stroke in patients with hypertrophic cardiomyopathy in stable sinus rhythm during long-term monitoring
Patients with hypertrophic cardiomyopathy (HCM) are at increased risk of stroke, but the incidence and factors associated with cardioembolic events in HCM patients without atrial fibrillation (AF) remain unresolved. We determined the incidence of stroke in patients in sinus rhythm (SR) monitored with a cardiac implantable electronic device (CIED).
Source: International Journal of Cardiology - April 13, 2023 Category: Cardiology Authors: Carlo Fumagalli, Francesca Bonanni, Matteo Beltrami, Roberta Ruggieri, Chiara Zocchi, Luigi Tassetti, Niccol ò Maurizi, Martina Berteotti, Mattia Zampieri, Alessia Argirò, Fabrizio Lovero, Alessia Tomberli, Mauro di Bari, Niccolò Marchionni, Paolo Pier Source Type: research
Atrial fibrillation burden and cognitive function; a new horizon in the digital health era?
Atrial fibrillation (AF) is the most prevalent clinical arrhythmia, is a major risk factor for stroke, and is associated with cardiovascular and total mortality. On the other hand, we have increasing evidence today on the association between AF and dementia which is another huge disease burden in the aging society. Numerous retrospective and prospective studies in recent years have reported a strong association between AF, cognitive decline, and dementia [1,2]. Such an association, however, need not be a causal relationship, because all these conditions very likely have a multifactorial interaction with other cardiovascula...
Source: International Journal of Cardiology - February 23, 2023 Category: Cardiology Authors: Ali Serdar Fak Tags: Editorial Source Type: research
The dilemma of thromboembolism prophylaxis in patient with acute heart failure
Despite advances in treatment, heart failure (HF) continues to be associated with high morbidity and mortality [1]. One of the reasons for this fact is the thrombogenicity seen in these patients through different mechanisms (Fig. 1) via Virchow's triad: blood stasis, endothelial dysfunction, and hypercoagulability; resulting in reported rates of up to 30% of venous thromboembolism (VTE), stroke, and sudden death among HF patients [2]. On the other hand, atrial fibrillation (AF) frequently coexists increasing the risk of thromboembolic events, and while the efficacy of anticoagulants in this last population has been proven ...
Source: International Journal of Cardiology - December 16, 2022 Category: Cardiology Authors: H. Amparo Taveras Tags: Editorial Source Type: research
Atrial fibrillation screening: Great debate on which approach to apply, which tools to use and which population to target
Atrial fibrillation (AF) is a common disease, particularly in the elderly and carries a substantial risk of stroke, which may be effectively prevented by the prescription of oral anticoagulants (OACs) in patients at risk [1]. This arrhythmia may appear in different forms (paroxysmal, persistent, permanent) and may be variably associated with an underlying cardiovascular disease (CVD). Regardless of this association, AF may be asymptomatic in a substantial proportion of cases, estimated to be around 30% [2].
Source: International Journal of Cardiology - December 11, 2022 Category: Cardiology Authors: Giuseppe Boriani, Jacopo Francesco Imberti, Marco Vitolo Tags: Editorial Source Type: research
Screening for high-grade asymptomatic carotid artery stenosis in nonvalvular atrial fibrillation
The plea for screening for asymptomatic carotid artery stenosis [1] should be extended to patients with the association of asymptomatic carotid artery stenosis (CAS) and nonvalvular atrial fibrillation(NVAF). The rationale is that it is already recognised that high-grade CAS(stenosis of 50% or more) is prevalent in about 12% of NVAF patients aged>70 [2]. Furthermore, in a study where 103 consecutive ischemic stroke patients with NVAF and were screened for CAS, high-grade extracranial CAS was identified in 25 subjects.
Source: International Journal of Cardiology - November 4, 2022 Category: Cardiology Authors: Oscar M.P. Jolobe Tags: Letter to the Editor Source Type: research
Screening for atrial fibrillation to prevent stroke in elderly individuals with or without preexisting cardiovascular disease: A post hoc analysis of the randomized LOOP study
This study aimed to investigate whether established cardiovascular diseases (CVD) could help to identify the population more likely to benefit from AF screening.
Source: International Journal of Cardiology - October 31, 2022 Category: Cardiology Authors: Lucas Yixi Xing, S øren Zöga Diederichsen, Søren Højberg, Derk W. Krieger, Claus Graff, Morten S. Olesen, Axel Brandes, Lars Køber, Ketil Jørgen Haugan, Jesper Hastrup Svendsen Source Type: research
Atrial high-rate episode burden and stroke risks for patients with device-detected subclinical atrial fibrillation: A systematic review and meta-analysis
Atrial high-rate episode (AHRE) and stroke are related; however, the magnitude of the correlations between different AHRE burdens and stroke remains unknown. We analysed studies that evaluated this relationship.
Source: International Journal of Cardiology - October 12, 2022 Category: Cardiology Authors: Yanhai Meng, Yanbo Zhang, Changsheng Zhu, Changrong Nie, Ping Liu, Shuo Chang, Shuiyun Wang Tags: Review Source Type: research
